Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

29.95
Delayed Data
As of 3:59pm ET
 +1.55 / +5.46%
Today’s Change
13.92
Today|||52-Week Range
30.37
+18.61%
Year-to-Date

Today’s Trading

Previous close28.40
Today’s open28.65
Day’s range28.46 - 30.20
Volume769,778
Average volume (3 months)556,816
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+528.57%
Earnings growth (this year)--
Earnings growth (next 5 years)+50.00%
Revenue growth (last year)+48.87%
P/E ratio17.0
Price/Sales6.07
Price/Book--

Competitors

 Today’s
change
Today’s
% change
INVAInnoviva Inc-0.06-0.46%
AXONAxovant Sciences Ltd+0.16+1.08%
PBYIPuma Biotechnology I...-0.40-1.00%
LXRXLexicon Pharmaceutic...-0.02-0.14%
Data as of 4:02pm ET, 03/24/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)$0.24
Annual revenue (last year)$215.0M
Annual profit (last year)$91.2M
Net profit margin42.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts


Search for Jobs